Investigators to examine Northwick Park trial safety

March 16, 2006
Research and Development

Two men involved in a UK clinical trial of new anti-inflammatory drug remain in a critical condition more than three …

World’s biggest DNA project launched

March 16, 2006
Research and Development DNA, MRC, UK Biobank, Wellcome

UK Biobank, the world’s largest and most detailed study of how genes, lifestyle and environment affect risks of developing disease, …

Deaths reported in dementia trial

March 16, 2006
Research and Development

Eleven patients have died in a study investigating Eisai/Pfizer's Aricept in the treatment of vascular dementia – but investigators say …

Pharma heading for collision course over cancer drug costs

March 16, 2006
Sales and Marketing

Fears that the pharmaceutical industry could be on a collision course with Europe's healthcare payers over new high priced medicines …

Making and shaping the headlines

March 15, 2006
Medical Communications

Most companies are anxious to court the media to ensure a clearer understanding of their business focus. However, the first …

A place in pharma’s history of innovation

March 15, 2006
Sales and Marketing prix galien

Registration has begun for entrants to the 2006 UK Prix Galien, which takes place at the Houses of Parliament this …

New NHS ratings take tougher line on financial performance

March 15, 2006

New NHS performance ratings will put equal emphasis on a trust's quality of care and financial management. The independent watchdog, …

Crestor hailed as first drug to reverse cardiovascular disease

March 14, 2006
Research and Development

Researchers have hailed results from a new study of Crestor which shows it can reverse atherosclerosis, the furring up of …

Schering to fight takeover bid from Merck KGaA

March 14, 2006
Sales and Marketing

A hostile takeover bid has been launched by Merck KGaA for rival German pharmaceutical company Schering.Both companies are enjoying strong …

We’re part of the solution, pharma tells Europe

March 13, 2006
Sales and Marketing

Europe’s pharmaceutical industry body EFPIA has launched a new promotional campaign for the sector, which it hopes will raise awareness …

NHS chief executive resigns amid financial crisis

March 10, 2006

NHS chief executive Nigel Crisp is to step down from the post as debts deepen in the health service.Significant improvements …

Bright future for NicOx after Pfizer glaucoma deal

March 10, 2006
Research and Development

Shares in the French biotechnology company NicOx have soared after Pfizer snapped up the rights to its pipeline of ophthalmology …

New Novartis blindness treatment filed in Europe

March 2, 2006
Sales and Marketing AMD, Lucentis, Novartis

Lucentis, a new treatment for neovascular age-related macular degeneration or ‘wet AMD’ has been submitted by Novartis to the European …

Herceptin challenges put patient safety at risk, says survey

March 2, 2006

NHS managers have warned that the sidelining of the normal regulatory process for new medicines will put patient safety at …

GSK launches Europe’s first rotavirus vaccine

March 1, 2006
Sales and Marketing

GlaxoSmithKline has launched Rotarix in Europe, the first ever marketed vaccine against rotavirus gastroenteritis, a common but potentially lethal condition …

Bioenvision’s leukaemia treatment gains positive opinion

March 1, 2006
Sales and Marketing

Bioenvision has received a positive opinion from the European Medicines Agency for Evoltra (clofarabine), the first drug specifically developed for …

Erbitux closer to head and neck cancer approval

March 1, 2006
Sales and Marketing

Merck KGaA's targeted cancer treatment Erbitux has moved a step closer to receiving EU approval to extend its licence to …

Novartis files new Hepatitis B treatment in Europe

February 28, 2006
Sales and Marketing

Novartis has filed its new hepatitis B treatment telbivudine in the European Union, and says it represents a potential new …

ABPI chief calls for ‘new rules of engagement’

February 23, 2006
Sales and Marketing

UK pharmaceutical industry leader Richard Barker has called for a fundamental rethink in the way the industry and the NHS …

Gene silencing technology to be used in war against bird flu

February 23, 2006
Sales and Marketing

Cutting edge technology will be used develop new drugs to treat dangerous strains of influenza, including the threat of a …

The Gateway to Local Adoption Series

Latest content